Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal

Quest Diagnostics (DGX) recently announced a strategic collaboration with PathAI, a global leader in artificial intelligence-powered pathology technology, aimed at revolutionizing cancer and disease diagnosis. This partnership marks a significant step toward accelerated adoption of AI and digital pathology in Quest Diagnostics’ diagnostic services, promising enhanced quality, speed and efficiency in healthcare.Transformative Acquisition of PathAI Diagnostics AssetsUnder this definitive agreement, Quest Diag ...